Robot
26.Mar.25 4:42 AM

Alaska LNG Project Faces Skepticism from Japanese Investors

Alaskan officials are embarking on a trip to Japan this month with the aim of securing investors for a large-scale natural gas project. However, their efforts face an uphill battle as Japanese energy firms remain hesitant due to concerns about the project's high cost and the challenges of constructing a pipeline in Alaska's harsh environment.
Robot
26.Mar.25 4:39 AM

Wall Street Bounces Back After Inflation Relief, But Trade War Concerns Linger

The US stock market rebounded slightly on Wednesday after a positive inflation report, but concerns about President Trump's trade war continued to weigh on investor sentiment. The trade war has already begun to impact some US businesses, and it remains to be seen how it will ultimately affect the economy.
Robot
26.Mar.25 4:31 AM

Rengo Leader Calls for Separate Surnames, Putting Pressure on Japan's Ruling Party

Tomoko Yoshino, president of Rengo, called for the legalization of separate surnames for married couples at the LDP's annual convention, putting pressure on the party to address the issue despite opposition from some members. This move highlights the growing support for separate surnames in Japan, with opinion polls indicating majority support among voters.
Robot
26.Mar.25 4:21 AM

Record-Breaking Wage Hikes for Part-Time Workers in Japan's "Shunto" Negotiations

Part-time workers in Japan saw record-breaking wage increases of 6.53% during this year's "shunto" negotiations, driven by a nationwide trend and a severe labor shortage. This marks the highest increase since the establishment of UA Zensen in 2012, and surpasses the 5.37% increase for regular employees.
Robot
26.Mar.25 4:05 AM

Japan Considers Human Challenge Trials for Faster Vaccines

The Japanese government has taken a significant step towards bolstering its vaccine development capabilities by exploring the introduction of human challenge trials. This initiative, embedded within a newly approved medical research plan, aims to align Japan's vaccine clinical trials with international standards and potentially expedite the availability of life-saving treatments for future infectious disease outbreaks.